Brief: Centessa Pharmaceuticals Unit Orexia Therapeutics, And Schrödinger Announce Collaboration

Centessa Pharmaceuticals

18/10/2021 16:18

Oct 18 (Reuters) - Centessa Pharmaceuticals PLC  260y.F :
    * CENTESSA PHARMACEUTICALS SUBSIDIARY, OREXIA THERAPEUTICS,
AND
SCHRÖDINGER ANNOUNCE COLLABORATION TO DISCOVER NOVEL OREXIN
RECEPTOR AGONISTS
    * CENTESSA PHARMACEUTICALS-COLLABORATION PROVIDES OREXIA
WITH
ACCESS TO SCHRÖDINGER'S ENTIRE COMPUTATIONAL PLATFORM
    * CENTESSA-OREXIA WILL BE RESPONSIBLE FOR PRECLINICAL
RESEARCH
ACTIVITIES,CLINICAL DEVELOPMENT,COMMERCIALIZATION OF FUTURE
PRODUCT CANDIDATES

Source text for Eikon:  ID:nBw5QkQRPa 
Further company coverage:  260y.F 

 ((Reuters.Briefs@thomsonreuters.com;))